These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15079908)

  • 1. [Interspecies differences of noopept pharmacokinetics].
    Boĭko SS; Korotkov SA; Zherdev VP; Gudasheva TA; Ostrovskaia RU; Voronina TA
    Eksp Klin Farmakol; 2004; 67(1):40-3. PubMed ID: 15079908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of new nootropic acylprolyldipeptide and its penetration across the blood-brain barrier after oral administration.
    Boiko SS; Ostrovskaya RU; Zherdev VP; Korotkov SA; Gudasheva TA; Voronina TA; Seredenin SB
    Bull Exp Biol Med; 2000 Apr; 129(4):359-61. PubMed ID: 10977920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of noopept and its active metabolite cycloprolyl glycine in rats].
    Boyko SS; Zherdev VP; Shevchenko RV
    Biomed Khim; 2018 Sep; 64(5):455-458. PubMed ID: 30378564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The original novel nootropic and neuroprotective agent noopept].
    Ostrovskaia RU; Gudasheva TA; Voronina TA; Seredenin SB
    Eksp Klin Farmakol; 2002; 65(5):66-72. PubMed ID: 12596521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proline-containing dipeptide GVS-111 retains nootropic activity after oral administration.
    Ostrovskaya RU; Mirsoev TK; Romanova GA; Gudasheva TA; Kravchenko EV; Trofimov CC; Voronina TA; Seredenin SB
    Bull Exp Biol Med; 2001 Oct; 132(4):959-62. PubMed ID: 11782792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preclinical study of noopept toxicity].
    Kovalenko LP; Smol'nikova NM; Alekseeva SV; Nemova EP; Sorokina AV; Miramedova MG; Kurapova SP; Sidorina EI; Kulakova AV; Daugel'-Dauge NO
    Eksp Klin Farmakol; 2002; 65(1):62-4. PubMed ID: 12025790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of non-NMDA glutamate receptors in the EEG effects of chronic administration of noopept GVS-111 in awake rats].
    Kovalev GI; Vorob'ev VV
    Eksp Klin Farmakol; 2002; 65(6):6-9. PubMed ID: 12596524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pharmacokinetics of the dipeptide analog of piracetam with nootropic activity GVS-111 and of its basic metabolites].
    Boĭko SS; Zherdev VP; Dvorianinov AA; Gudasheva TA; Ostrovskaia RU; Voronina TA; Rozantsev GG; Seredenin SB
    Eksp Klin Farmakol; 1997; 60(2):53-5. PubMed ID: 9206571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of N-[N-[3-(3-hydroxy-4-methoxyphenyl) propyl]-α-aspartyl]-L-phenylalanine 1-methyl ester, monohydrate (advantame) in the rat, dog, and man.
    Ubukata K; Nakayama A; Mihara R
    Food Chem Toxicol; 2011 Nov; 49 Suppl 1():S8-29. PubMed ID: 22036030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-inflammatory properties of noopept (dipeptide nootropic agent GVS-111)].
    Kovalenko LP; Miramedova MG; Alekseeva SV; Gudasheva TA; Ostrovskaia RU; Seredenin SB
    Eksp Klin Farmakol; 2002; 65(2):53-5. PubMed ID: 12109295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the long-term behavioral effects of noopept and piracetam in adult male rats and female rats in postnatal period].
    Voronina TA; Guzevatykh LS; Trofimov SS
    Eksp Klin Farmakol; 2005; 68(2):3-7. PubMed ID: 15934357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficiency of noopept in streptozotocin-induced diabetes in rats.
    Ostrovskaya RU; Ozerova IV; Gudascheva TA; Kapitsa IG; Ivanova EA; Voronina TA; Seredenin SB
    Bull Exp Biol Med; 2013 Jan; 154(3):334-8. PubMed ID: 23484194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The original nootropic and neuroprotective drug noopept potentiates the anticonvulsant activity of valproate in mice].
    Kravchenko EV; Ponteleeva IV; Trofimov SS; Lapa VI; Ostrovskaia RU; Voronina TA
    Eksp Klin Farmakol; 2009; 72(6):15-7. PubMed ID: 20095393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics of hopantenic acid upon peroral administration].
    Karlina MV; Pozharitskaia ON; Kosman VM; Shikov AN; Lazukina MA; D'iachuk GI
    Eksp Klin Farmakol; 2010 Aug; 73(8):46-8. PubMed ID: 20919560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior of mice from different strains: modifications produced by noopept].
    Bel'nik AP; Ostrovskaia RU; Poletaeva II
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2007; 57(5):613-7. PubMed ID: 18064900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics of n-(5-oxynicotinoyl)-L-glutamic acid calcium salt upon bolus administration in rats and rabbits: interspecies extrapolation].
    Firsov AA; Portnoĭ IuA; Dovzhenko SA; Kobrin MB; Kiselev AV; Stovbun SV; Dolgova GV; Pomerantseva TIa
    Eksp Klin Farmakol; 2010 Dec; 73(12):31-5. PubMed ID: 21395015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the novel dipeptide nootropic agent noopept and its metabolite cyclo-L-prolylglycine on the transcallosal evoked potential in the rat brain].
    Molodavkin GM; Borlikova GG; Voronina TA; Gudasheva TA; Ostrovskaia RU; Tushmalova NA; Seredenin SB
    Eksp Klin Farmakol; 2002; 65(2):3-5. PubMed ID: 12109288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nootropics on the EEG in conscious rats and their modification by glutamatergic inhibitors.
    Vorobyov V; Kaptsov V; Kovalev G; Sengpiel F
    Brain Res Bull; 2011 May; 85(3-4):123-32. PubMed ID: 21414388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of aniracetam and its metabolites in rats.
    Ogiso T; Iwaki M; Tanino T; Ikeda K; Paku T; Horibe Y; Suzuki H
    J Pharm Sci; 1998 May; 87(5):594-8. PubMed ID: 9572910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.